The Genomic Medicine for Ill Neonates and Infants (GEMINI) Trial: A Comparative Analysis between Rapid Whole Genomic Sequencing and a Targeted Exome Panel

Monday, April 25, 2022

2:15 PM – 2:30 PM US MT

Location: Convention Center: Mile High Ballroom 4AB

CE: Enduring CME: 0.25

Publication Number: 3580.6

Jill Maron, Women & Infants Hospital of Rhode Island, Providence, RI, United States; Stephen F. Kingsmore, Rady Children's Institute for Genomic Medicine, San Diego, CA, United States; Bruce D. Gelb, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Jerry Vockley, Univresity of Pittsburgh School of Medicine, Pittsburgh, PA, United States; Cynthia M. Powell, the University of North Carolina School of Medicine, Chapel Hill, NC, United States; Brenda Poindexter, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, United States; Thomas Diacovo, UPMC Childrens Hospital of Pittsburgh, Pittsburgh, NY, United States; Jae H. Kim, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Dallas Reed, Tufts Childrens Hospital, Boston, MA, United States; Kristen Wigby, University of California, San Diego School of Medicine, San Diego, CA, United States; Jennifer Bragg, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Andrea Trembath, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States; Annemarie Stroustrup, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, United States; Kristen Suhrie, Indiana University School of Medicine, Indianapolis, IN, United States; Anne Kurfiss, Tufts Childrens Hospital, Boston, MA, United States; Jonathan M. Davis, Tufts Childrens Hospital, Boston, MA, United States

Presenting Author(s)

Jill Maron, MD, MPH
Pediatrician-in-Chief
Women & Infants Hospital of Rhode Island
Sharon, Massachusetts, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Jill Maron, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Stephen F. Kingsmore, MB, ChB, BAO, DSc, FRCPath: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Bruce D. Gelb, M.D.: ● AavantiBio (Currently Ongoing) (Products/Services: Consultant).
● Correlegan (Currently Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties).
● Day One Therapeutics (Currently Ongoing) (Products/Services: Consultant).
● GeneDx (Currently Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties).
● Lab Corp (Currently Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties).
● Onconova Therapeutics (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
● Prevention Genetics (Currently Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties).

Jerry Vockley, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Cynthia M. Powell, Powell, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Brenda Poindexter, MD MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Thomas Diacovo, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Jae H. Kim, MD, PhD: ● Astarte Medical (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Evolve Biosystems (Ended In the Past 24 Months) (Products/Services: Advisory Committee).
● Ferring Pharmaceutical (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
● Fujifilm (Ended In the Past 24 Months) (Products/Services: Consultant).
● Innara Health (Currently Ongoing) (Products/Services: Board Member or Executive Role).
● Medela (Currently Ongoing) (Products/Services: Advisory Committee).
● Nicolette (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Nutricia (Ended In the Past 24 Months) (Products/Services: Consultant).

Dallas Reed, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Kristen Wigby, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Jennifer Bragg, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Andrea Trembath, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Annemarie Stroustrup, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Kristen Suhrie, MD: ● Illumina (Ended In the Past 24 Months) (Products/Services: Consultant).

Anne Kurfiss, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Jonathan M. Davis, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.